We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
(+4.6%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$188M |
| 2 |
Labcorp
LH
|
+$183M |
| 3 |
AGN
Allergan Inc
AGN
|
+$144M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$93.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$82.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$104M |
| 2 |
Cardinal Health
CAH
|
+$104M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.7M |
| 4 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$60.3M |
| 5 |
Elevance Health
ELV
|
+$55.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.3% |
| 2 | Consumer Discretionary | 5.38% |
| 3 | Financials | 4.49% |
| 4 | Industrials | 3.37% |
| 5 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
NetApp
NTAP
$34.1B
| $1.09M | 0.02% |
26,371
+11,992
| +83% | +$498K |
|
502
East-West Bancorp
EWBC
$17.9B
| $1.09M | 0.02% |
28,121
-7,604
| -21% | -$275K |
|
503
Monster Beverage
MNST
$95.5B
| $1.09M | 0.02% |
60,186
-125,148
| -68% | -$2.16M |
|
504
Caterpillar
CAT
$373B
| $1.08M | 0.02% |
11,849
-5,981
| -34% | -$582K |
|
505
Hershey
HSY
$35.9B
| $1.08M | 0.02% |
+10,359
| New | +$1.01M |
|
506
CALL
International Paper
IP
$22.8B
| $1.07M | 0.02% |
21,120
+21,014
| +19,825% | +$1.03M |
|
507
Invesco
IVZ
$13B
| $1.06M | 0.02% |
+26,902
| New | +$1.06M |
|
508
Republic Services
RSG
$65B
| $1.06M | 0.02% |
26,343
+6,020
| +30% | +$236K |
|
|
AFSI
509
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $1.06M | 0.01% |
37,574
+1,682
| +5% | +$42.3K |
|
510
Pitney Bowes
PBI
$2.46B
| $1.05M | 0.01% |
43,210
+8,963
| +26% | +$219K |
|
|
FCS
511
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $1.05M | 0.01% |
62,124
+16,332
| +36% | +$254K |
|
512
Merck
MRK
$321B
| $1.04M | 0.01% |
19,283
+8,069
| +72% | +$450K |
|
513
Aflac
AFL
$64.8B
| $1.04M | 0.01% |
34,144
-144,554
| -81% | -$4.27M |
|
514
Northrop Grumman
NOC
$76B
| $1.04M | 0.01% |
7,046
+3,178
| +82% | +$436K |
|
515
HCA Healthcare
HCA
$85.7B
| $1.04M | 0.01% |
14,129
-244,243
| -95% | -$17.2M |
|
516
Aon
AON
$78.3B
| $1.04M | 0.01% |
+10,922
| New | +$977K |
|
|
IHS
517
DELISTED
IHS INC CL-A COM STK
IHS
| $1.03M | 0.01% |
9,061
+1,436
| +19% | +$178K |
|
518
Parker-Hannifin
PH
$121B
| $1.03M | 0.01% |
7,959
-3,162
| -28% | -$388K |
|
519
Principal Financial Group
PFG
$24.5B
| $1.02M | 0.01% |
+19,702
| New | +$1.02M |
|
520
APA Corp
APA
$12.8B
| $1.02M | 0.01% |
+16,293
| New | +$1.16M |
|
521
Intuit
INTU
$86.3B
| $1.02M | 0.01% |
+11,068
| New | +$984K |
|
522
Valley National Bancorp
VLY
$7.92B
| $1.02M | 0.01% |
104,916
+78,782
| +301% | +$763K |
|
523
Ford
F
$59.3B
| $1.02M | 0.01% |
65,528
-9,233
| -12% | -$136K |
|
524
Sysco
SYY
$40.6B
| $996K | 0.01% |
25,092
+14,490
| +137% | +$562K |
|
525
O'Reilly Automotive
ORLY
$72.4B
| $994K | 0.01% |
77,355
-1,290
| -2% | -$15.1K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.
- Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
- Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
- Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
- Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
- Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
- Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
- Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.
Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.